Lv X - Search Results

1

Impact of magnetic resonance imaging-derived skeletal muscle index in locoregionally advanced nasopharyngeal carcinoma.

Jiang J, Cai Z, Zheng R, Yuan Y, Lv X, Qiu W. Jiang J, et al. Among authors: lv x. Eur Arch Otorhinolaryngol. 2024 Apr 26. doi: 10.1007/s00405-024-08572-6. Online ahead of print. Eur Arch Otorhinolaryngol. 2024. PMID: 38671169

2

Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment.

Lv X, Xiang YQ, Cao SM, Qian CN, Li NW, Guo L, Mai HQ, Chen QY, Huang PY, Luo D, Cao KJ, Hong MH, Guo X. Lv X, et al. Head Neck. 2011 Jun;33(6):780-5. doi: 10.1002/hed.21541. Epub 2010 Oct 21. Head Neck. 2011. PMID: 20967862

3

Prospective study of prognostic value of Raf kinase inhibitory protein and pretreatment plasma Epstein-Barr virus DNA for distant metastasis in locoregionally advanced nasopharyngeal carcinoma.

Li SW, Wang H, Xiang YQ, Zhang HB, Lv X, Xia WX, Zeng MS, Mai HQ, Hong MH, Guo X. Li SW, et al. Among authors: lv x. Head Neck. 2013 Apr;35(4):579-91. doi: 10.1002/hed.23009. Epub 2012 May 18. Head Neck. 2013. PMID: 22605662

4

Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area.

Liang H, Xiang YQ, Lv X, Xie CQ, Cao SM, Wang L, Qian CN, Yang J, Ye YF, Gan F, Ke LR, Yu YH, Liu GY, Qiu WZ, Huang XJ, Wen CH, You N, Wang XQ, Guo X, Xia WX. Liang H, et al. Among authors: lv x. Eur J Cancer. 2017 Mar;73:48-60. doi: 10.1016/j.ejca.2016.12.009. Epub 2017 Feb 3. Eur J Cancer. 2017. PMID: 28161498

5

Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.

Ke LR, Xia WX, Qiu WZ, Huang XJ, Yang J, Yu YH, Liang H, Liu GY, Ye YF, Xiang YQ, Guo X, Lv X. Ke LR, et al. Among authors: lv x. BMC Cancer. 2017 Feb 15;17(1):134. doi: 10.1186/s12885-017-3080-4. BMC Cancer. 2017. PMID: 28202000 Free PMC article. Clinical Trial.

6

Combining cetuximab with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: A propensity score analysis.

Xia WX, Liang H, Lv X, Wang L, Qian CN, Ye YF, Ke LR, Qiu WZ, Yu YH, Huang XJ, Liu GY, Zhao C, Xiang YQ, Guo X. Xia WX, et al. Among authors: lv x. Oral Oncol. 2017 Apr;67:167-174. doi: 10.1016/j.oraloncology.2017.02.026. Epub 2017 Mar 2. Oral Oncol. 2017. PMID: 28351572

7

A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.

Ke LR, Xia WX, Qiu WZ, Huang XJ, Yu YH, Liang H, Liu GY, Xiang YQ, Guo X, Lv X. Ke LR, et al. Among authors: lv x. Oral Oncol. 2017 Jul;70:7-13. doi: 10.1016/j.oraloncology.2017.04.018. Epub 2017 May 9. Oral Oncol. 2017. PMID: 28622892 Clinical Trial.

8

A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy.

Qiu WZ, Ke LR, Xia WX, Yang J, Yu YH, Liang H, Huang XJ, Liu GY, Li WZ, Xiang YQ, Guo X, Lv X. Qiu WZ, et al. Among authors: lv x. PLoS One. 2017 Aug 10;12(8):e0182963. doi: 10.1371/journal.pone.0182963. eCollection 2017. PLoS One. 2017. PMID: 28797119 Free PMC article.

9

The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling.

Qiu WZ, Zhang HB, Xia WX, Ke LR, Yang J, Yu YH, Liang H, Huang XJ, Liu GY, Li WZ, Xiang YQ, Kang TB, Guo X, Lv X. Qiu WZ, et al. Among authors: lv x. J Exp Clin Cancer Res. 2018 Apr 17;37(1):85. doi: 10.1186/s13046-018-0722-6. J Exp Clin Cancer Res. 2018. PMID: 29665837 Free PMC article.

10

Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.

Liu GY, Lv X, Wu YS, Mao MJ, Ye YF, Yu YH, Liang H, Yang J, Ke LR, Qiu WZ, Huang XJ, Li WZ, Guo X, Xiang YQ, Xia WX. Liu GY, et al. Among authors: lv x. Cancer Commun (Lond). 2018 May 10;38(1):21. doi: 10.1186/s40880-018-0283-2. Cancer Commun (Lond). 2018. PMID: 29764487 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,900 results

Search Page